Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Reyhan Diz- Küçükkaya"'
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 3, Pp 167-174 (2024)
Objective: It has been shown that clonal mutations occur in hematopoietic stem cells with advancing age and increase the risk of death due to atherosclerotic vascular diseases, similarly to myeloproliferative neoplasms. Endothelial cells (ECs) and he
Externí odkaz:
https://doaj.org/article/f04aaa0a9bfe440194da9214eca79eaf
Publikováno v:
Turkish Journal of Hematology, Vol 30, Iss 1, Pp 8-12 (2013)
OBJECTIVE: The MPL gene encodes the thrombopoietin receptor. Recently MPL mutations (MPL W515L or MPL W515K) were described in patients with essential thrombocythemia (ET) and primary (idiopathic) myelofibrosis (PMF). The prevalence and the clinical
Externí odkaz:
https://doaj.org/article/158ca4292e6b46ada24547765caf25dd
Autor:
Zehra Narlı Özdemir, Yıldız İpek, Püsem Patır, Gözde Ermiş, Rafiye Çiftçiler, Deniz Özmen, Mehmet Baysal, Vildan Gürsoy, Esra Yıldızhan, Serkan Güven, Tarık Ercan, Tayfun Elibol, Sinan Mersin, Eylem Genç, Eren Arslan Davulcu, Volkan Karakuş, Nergiz Erkut, Gürsel Güneş, Reyhan Diz Küçükkaya, Ahmet Emre Eşkazan
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 1, Pp 26-36 (2024)
Objective: In this study, we investigated the effects of calreticulin (CALR) and JAK2V617F mutational status on clinical course and disease outcomes in Turkish patients with essential thrombocythemia (ET). Materials and Methods: Seventeen centers fr
Externí odkaz:
https://doaj.org/article/ab5f757b27aa42b59fc159ec0b70c9e6
Autor:
Mehmet Baysal, Fehmi Hindilerden, Elif Gülsüm Umit, Ahmet Muzaffer Demir, Fatma Keklik Karadağ, Güray Saydam, Seval Akpınar, Burhan Turgut, Vildan Özkocaman, Fahir Özkalemkaş, Rafiye Çiftçiler, Can Özlü, Sinan Demircioğlu, Yıldız İpek, Reyhan Diz Küçükkaya
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 4, Pp 251-257 (2023)
Objective: In recent years, new developments have been incorporated into daily practice in the management of immune thrombotic thrombocytopenic purpura (iTTP). In particular, clinical scoring systems could help clinicians with clinical decision-makin
Externí odkaz:
https://doaj.org/article/e89a463303e642d4a3be2d616bf175e6
Autor:
Neslihan Uslu, Zahide Taş, Tuğba Naziroğlu, Nergiz Ekmen, Buket Yağcı, Hadi Sasani, Pınar Özkan Epöztürk, Semih Sözen, Reyhan Diz Küçükkaya, Nalan Ünel Özcan
Publikováno v:
European Archives of Medical Research. 38:117-124
Objective: Dynamic changes in the number of eosinophils are observed during the diagnosis and follow-up in coronavirus disease-2019(COVID-19). Our aim was to show the role of the absolute eosinophil count in the diagnosis of COVID-19 and the relation
Autor:
Ömer Uludağ, Erhan Çene, Erdem Gurel, Çiğdem Çetin, Murat Bektaş, Yasemin Yalçınkaya, Reyhan Diz-Küçükkaya, Ahmet Gül, Murat Inanç, Bahar Artim-Esen
Publikováno v:
Lupus. 31:433-442
Objective To identify the different clinical phenotypes of antiphospholipid syndrome (APS) by using cluster analysis and describe cumulative damage of disease clusters. Methods This retrospective study includes patients with APS (±systemic lupus ery
Publikováno v:
Journal of the Turkish German Gynecological Association. 23(4)
Personalized medicine is a relatively new and interesting concept in the medical and healthcare industries. New approaches in current research have supported the search for biomarkers, based on the genomic, epigenomic and proteomic profile of individ
Autor:
Nurcan Özçelik, Hasan Sami Göksoy, Serkan Güvenç, Deniz Goren Sahin, Emine Tülay Özçelik, Burcu Kurt Yildirim, Fehmi Hindilerden, Mutlu Arat, Reyhan Diz Küçükkaya
Publikováno v:
Ege Tıp Dergisi. 59:109-112
Amaç: Primer miyelofibrozis (PMF), kronik miyeloproliferasyon, atipik megakaryositik hiperplazi ve kem k l ğ f broz s le karakter ze klonal b r kök hücre hastalığıdır. Bu hastalarda günümüzde halen göster leb lm ş tek şifa sağlayıcı
Autor:
Deniz Goren Sahin, Nurcan Özçelik, Mutlu Arat, Reyhan Diz Küçükkaya, Emine Tülay Özçelik, Fehmi Hindilerden, Burcu Kurt Yildirim
Publikováno v:
LLM Dergi. 4:32-37
Autor:
Ali Zahit Bolaman, İdris İnce, Zübeyde Nur Özkurt, Elgün Abishov, Ömür Gökmen Sevindik, Hüseyin Saffet Beköz, Ahmet Muzaffer Demir, Irfan Yavasoglu, Veysel Erol, Muzaffer Keklik, Zeynep Arzu Yegin, Arzu Akyay, Vildan Ozkocaman, Hilal Eroğlu Küçükdiler, Münci Yağcı, Meral Beksac, Gunhan Gurman, Cem Selim, Meltem Kurt Yuksel, Ali Dogan, Vildan Gürsoy, Serhat Çelik, Senem Maral, Umut Yilmaz, Leylagül Kaynar, Osman Ilhan, Hava Üsküdar Teke, Güner Hayri Özsan, Berrin Balık Aydın, Ufuk Demirci, Unal Atas, Selami Kocak Toprak, Sinem Civriz Bozdag, Fahir Özkalemkaş, Tekin Aksu, Nil Güler, Guldane Cengiz Seval, Reyhan Diz Küçükkaya, Özcan Çeneli, Yaşa Gül Mutlu, Eren Gündüz, Lale Aydın Kaynar, Sule Unal, Volkan Baş, Boran Yavuz, Pervin Topcuoglu, Hatice Terzi, Fehmi Hindilerden, Zeynep Tuğba Güven, Canan Albayrak, Yasemin Yavuz, Ferda Can, Muhlis Cem Ar, Neslihan Andic, İpek Yönal Hindilerden, Sinan Demircioğlu, Hasan Sami Goksoy, Rafiye Ciftciler, Mustafa Baydar, Soğol Sadri, Muhit Ozcan, Hamza Abbasov, Orhan Kemal Yücel, Sevil Sadri
Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly immunosuppressed populations, such as in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a0e580151a54b4a20ef926b2166df4c
https://avesis.deu.edu.tr/publication/details/82513f28-7a67-4796-aeda-6d220d3d7f2b/oai
https://avesis.deu.edu.tr/publication/details/82513f28-7a67-4796-aeda-6d220d3d7f2b/oai